- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06868524
Leading Healthy Eating and Activity Promotion Program (LEAP)
May 14, 2026 updated by: Laura Q. Rogers, MD, MPH, University of Alabama at Birmingham
Leveraging Adaptation and Multilevel Implementation Strategies to Address Unique Health Promotion Challenges Among Cancer Survivors
The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support.
This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sydney McGlawn
- Phone Number: 205-934-8821
- Email: sburdette@uabmc.edu
Study Contact Backup
- Name: Marie-Therese Cooper
- Phone Number: 205-934-6897
- Email: marietheresejcooper@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35243
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Sydney McGlawn
- Phone Number: 205-934-8821
- Email: sburdette@uabmc.edu
-
Principal Investigator:
- Laura Rogers, MD
-
Sub-Investigator:
- Lisa Zubkoff, PhD
-
Contact:
- Marie-Therese Cooper
- Phone Number: 205-934-6897
- Email: marietheresejcooper@uabmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Study Population
cancer survivors or the friend/family member of a cancer survivor
Description
Inclusion Criteria:
- Between the ages of 18 and 89
- English speaking
- Resident of Birmingham area or surrounding community
- History of any type of cancer or the friend or family with of a cancer survivor
Exclusion Criteria:
- Serious difficulty hearing
- History of dementia or organic brain syndrome
- On primary treatment for cancer
- No other other medical, psychological, or social characteristic that would interfere with participation in evaluation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Program participants
Agree to evaluate a community-based, publicly available program combining a website with optional in person group sessions.
|
Combines a publicly available website with educational materials related to healthy eating, regular exercise, and a healthy body weight.
Interested community members can also join optional in person community-based events that reinforce the educational material on the website.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weekly intake of vegetables, fruit, and sugar sweetened beverages
Time Frame: Baseline, 12 weeks
|
Each participant reports the average times per week they eat vegetables, eat fruit, and drink sugar sweetened beverages
|
Baseline, 12 weeks
|
|
Average time spent doing physical activity based on accelerometer
Time Frame: Baseline, 12 weeks
|
Measuring physical activity from one-week of wearing an accelerometer
|
Baseline, 12 weeks
|
|
Body mass index (BMI)
Time Frame: Baseline, 12 weeks
|
Trained research staff will measure height using portable stadiometer (baseline only; no shoes) and weight using portable calibrated scale (light clothing without shoes) to calculate BMI (weight in kg/height in meters squared)
|
Baseline, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall quality of life score
Time Frame: Baseline, 12-weeks
|
self reported survey to collect data about physical, mental, and social health on a scale of 1 to 5 with 5 being excellent and 1 being poor
|
Baseline, 12-weeks
|
|
Self-report physical activity
Time Frame: Baseline, 12 weeks
|
Participants report time per day or week doing moderate intensity physical activity, doing vigorous intensity physical activity, walking, and sitting.
|
Baseline, 12 weeks
|
|
Evaluation of the LEAP Program
Time Frame: 12 weeks
|
Participants complete a survey about the LEAP Program activities they did and feedback on the program
|
12 weeks
|
|
Physical performance
Time Frame: Baseline, 12 weeks
|
Number of times a participant can stand up from a chair in 30 seconds and the time it takes for a participant to stand up from a chair, walk 10 feet, and return to sit in the chair
|
Baseline, 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant demographic characteristics
Time Frame: Baseline
|
Participants complete a survey asking about demographic characteristics (age, sex, race, residence, education, income, employment, etc.)
|
Baseline
|
|
Participant medical and lifestyle characteristics
Time Frame: Baseline, 12 weeks
|
Participants complete a survey about their medical (cancer history, comorbidities), and lifestyle (alcohol, smoking) characteristics.
|
Baseline, 12 weeks
|
|
Food access
Time Frame: Baseline, 12 weeks
|
Participants complete a survey asking about the availability of low-fat foods, vegetables, and fruits in their neighborhood
|
Baseline, 12 weeks
|
|
Neighborhood walkability
Time Frame: Baseline, 12 weeks
|
Participants complete a survey asking about how easy it is to walk to places in their neighborhood.
|
Baseline, 12 weeks
|
|
Prior participation in the LEAP Program
Time Frame: Baseline
|
Participants complete questions about any prior participation in LEAP Program activities or use of the website
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Laura Rogers, MD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 30, 2025
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
March 1, 2029
Study Registration Dates
First Submitted
March 5, 2025
First Submitted That Met QC Criteria
March 5, 2025
First Posted (Actual)
March 11, 2025
Study Record Updates
Last Update Posted (Actual)
May 19, 2026
Last Update Submitted That Met QC Criteria
May 14, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300010921
- 1U54CA280770-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individuals interested in requesting IPD should contact the study PIs.
IPD Sharing Time Frame
After data management is finalized (and data locked) and the main outcomes manuscript has been submitted.
IPD Sharing Access Criteria
A data use agreement between the institution housing the data (UAB) and the institution of the requesting researcher will be required.
IPD Sharing Supporting Information Type
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on LEAP Program
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Rheumatology | Hand Rheumatism | Video Games
-
Seattle Children's HospitalNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Medipol UniversityRecruitingCerebral Palsy (CP)Turkey (Türkiye)
-
Oxford Biomedical Technologies, Inc.Active, not recruitingIBS - Irritable Bowel SyndromeUnited States
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
University of Massachusetts, WorcesterNational Institute of Nursing Research (NINR)CompletedHepatitis cUnited States
-
VA Office of Research and DevelopmentCompletedSuicidal Self-directed Violence | Suicidal Preparatory BehaviorUnited States
-
Tulane UniversityUniversity of Alabama at Birmingham; Louisiana State University Health Sciences... and other collaboratorsTerminated
-
Cardiff UniversityCompletedMultiple SclerosisUnited Kingdom